Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1120 of 5804
-
Vibrating platform may improve balance and thinking in Parkinson's
Symptom relief OngoingThe aim of this study is to evaluate the effects of different frequencies of Whole Body Vibration (WBV) application on balance, gait, cognitive functions, and dual-task performance in patients with Parkinson's disease. Study Hypotheses: H0.1 - There is no effect of different fr…
Phase: NA • Sponsor: Izmir Bakircay University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Can a phone app curb suicidal urges? new trial aims to find out
Symptom relief Recruiting nowThis study aims to evaluate the acceptability, safety, and preliminary efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide id…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Designer cells aim to calm immune system after massive heart attack
Disease control Not yet recruitingTo study the safety and efficacy of fibroblast activation protein (FAP)-targeted allogeneic immunosuppressive chimeric antigen receptor-dendritic cell (CAR-DC) in the treatment of acute myocardial infarction with cardiogenic shock and provide a new method for the treatment of acu…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Experimental 'Off-the-Shelf' NK cells aim to fight childhood leukemia
Disease control Not yet recruitingThis is a single-arm, open-label, dose-escalation and expansion, prospective clinical trial conducted in patients with relapsed or refractory pediatric B-cell acute lymphoblastic leukemia to evaluate the safety and efficacy of JY509 universal NK cell injection.
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Gallstone breakthrough: no surgery needed?
Disease control ENROLLING_BY_INVITATIONGallstones, as a common benign gallbladder disease worldwide, have a prevalence of approximately 6.1%. Although laparoscopic cholecystectomy (LC) is currently the mainstream treatment, its associated complications cannot be overlooked, including intra-abdominal bleeding, bile lea…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a tiny dose of radiation slow Parkinson's? mayo clinic launches first test.
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to investigate the use of ultra-low, anti-inflammatory doses of radiation therapy (RT) for the treatment of Parkinson's Disease (PD). In this study, the TrueBeam LINAC utilizes a linear accelerator (LINAC) for the delivery of radiation therapy. Dynami…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tests simple ways to prevent dangerous sodium drop after brain surgery
Prevention Recruiting nowThe investigators are conducting this study to investigate new preventive measures for patients with low sodium levels (hyponatremia), which can occur after surgery on the pituitary gland. This hyponatremia is often caused by the syndrome of inappropriate antidiuresis (SIAD). SIA…
Phase: NA • Sponsor: University Hospital, Basel, Switzerland • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New trial aims to find safer treatment for dangerous scar pregnancy
Disease control Not yet recruitingThe aim of the study is to compare the effectiveness and the complications of Ultrasound guided surgical evacuation versus using combined local and systemic methotrexate injection for management of caesarean scar pregnancy.
Phase: PHASE2 • Sponsor: Minia University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New study tests Brain-Saving drugs for stroke patients
Disease control Not yet recruitingThis study conducted a comprehensive evaluation of commonly used neuroprotective agents in acute ischemic stroke, assessing their real-world value across six dimensions: safety, efficacy, cost-effectiveness, innovativeness, appropriateness, and accessibility. Employing a prospect…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New antibody trio takes on Hard-to-Treat lymphoma
Disease control Recruiting nowThe purpose of this study is to determine the putative recommended Phase 2 doses (RP2Ds) and optimal dose schedule(s) for JNJ-95566692 as a single agent (Arm A) and in combination with JNJ-87801493 (Arm B) (Part 1: Dose Escalation) and to further characterize the safety and clini…
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New pill could replace steroids for painful muscle condition
Disease control Not yet recruitingThe study intends to explore the efficacy and safety of Ivarmacitinib in therapy for polymyalgia rheumatica through a multicenter, randomized, double-blind, placebo-controlled study, and to explore the effectiveness of Ivarmacitinib as an oral glucocorticoid-sparing alternative i…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New hope for advanced GI cancers: first human trial launches
Disease control Recruiting nowThis study, the first clinical trial, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of DB-1324.
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New cocktail of drugs aims to tackle tough pancreatic cancer
Disease control Not yet recruitingThis study is a prospective, open-label, single-arm clinical trial evaluating the safety and efficacy of tunlametinib in combination with gemcitabine/albumin-bound paclitaxel and an EGFR monoclonal antibody as first-line therapy in treatment-naive subjects with advanced pancreati…
Phase: PHASE4 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New weekly shot shows promise for diabetes and weight loss
Disease control Recruiting nowThis is a phase II, randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of GL0034 among type II diabetes mellitus subjects who are obese or overweight with weight-related comorbidities. Subjects will be put on either one of the four treatm…
Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New Ultrasound-Guided procedure could reduce bleeding risk in cirrhosis patients
Disease control Not yet recruitingBleeding from esophagogastric varices in patients with liver cirrhosis is often life-threatening. Thrombocytopenia caused by hypersplenism secondary to portal hypertension is an independent risk factor for such gastrointestinal bleeding. Studies have confirmed that partial spleni…
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Psoriasis drug combo aims to tackle skin and cholesterol in one shot
Disease control Not yet recruitingThe aim is to evaluate the safety and efficacy of vunakizumab combined with recaticimab versus vunakizumab combined with placebo in the treatment of plaque psoriasis with dyslipidemia.
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New depression pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThis study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Weight-Loss drug may boost IVF success for overweight women
Symptom relief Recruiting nowThis is a randomized, controlled clinical trial with a two-sided superiority hypothesis. The study evaluates whether a 12-week pre-treatment with semaglutide prior to ovarian stimulation improves the number of good-quality blastocysts in overweight and obese women undergoing in v…
Phase: PHASE4 • Sponsor: Fundacion Dexeus • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Can East-Meet-West medicine slow spine damage in ankylosing spondylitis?
Disease control Recruiting nowThis study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from the three years prior to enrolment, and a prospective follow-up period of up to two years. The study is designed to eva…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Smart blood test aims to end blood pressure medication guesswork
Disease control Not yet recruitingHigh blood pressure (hypertension) affects 1 in 3 adults and can lead to serious health issues like strokes and heart attacks. Medication can lower blood pressure (BP) and reduce complications. Choosing the right medication can be challenging, potentially leading to side effects …
Phase: NA • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC